This strategic partnership will give customers the ability to access to a wide array of projects' valuations tools through the LifeScience-Portal™ which brings intuitive databases for R&D and competitive intelligence. It will also offer business development and market scouting services thanks to CBDM.T® expertise. Consequently, customers will benefit from insights into competitors, products, trends, opportunities and market threats. Each company will be bringing its professional network into play in order to evaluate and respond to markets critical needs (IP, Manufacturing/Production, Biotech, MedTech, Fine chemical, Cosmetics, and Financial services). ”Working together will be a key to our customers’ expectations of not only reading the market but also scouting the market to build in or perform business cases”, said M. Philippe Tramoy, Managing Partner, CBDM.T® Ltd, commenting this joint venture. “By bringing the cutting edge in dynamic valuation tools and business development expertise we will form the basis of a strong relationship with our customers", added Dr. Bisognano Carmelo, LifeScience-Consulting CEO.
LifeScience-Consulting, Inc. is a company focused on the integration of financial and scientific data to provide sophisticated computer models and cutting edge industry knowledge. The Company markets the Lifescience-Portal™, a fully integrated information infrastructure platform improving the complex valuation of pharma/biotech companies and projects. Additionally, the Lifescience-Reports™ are shaped to match specifically customers' demands for market analysis, due diligence and projects' valuations.
CBDMT® is a services company providing to small, medium size and large industrial companies a technology-based business development support to identify new customers. Typically, CBDMT® interacts with its clients as business development partner to maximize effectiveness and minimize risks to sound out international markets (WOI - Window Opportunity Identification).